Sabra Health Care REIT, Inc. (SBRA) — Analyst outlook / Analyst consensus target is. Based on 29 analyst ratings, the consensus is bullish — 11 Buy, 16 Hold, 2 Sell.
The consensus price target is $21.33 (low: $21.00, high: $22.00), representing an upside of 4.9% from the current price $20.34.
Analysts estimate Earnings Per Share (EPS) of $0.51 and revenue of $0.69B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.54 vs est $0.51 (beat +6.9%). 2025: actual $0.64 vs est $0.70 (missed -8.1%). Analyst accuracy: 92%.
SBRA Stock — 12-Month Price Forecast
$21.33
▲ +4.87% Upside
Average Price Target
Based on 29 Wall Street analysts offering 12-month price targets for Sabra Health Care REIT, Inc., the average price target is $21.33, with a high forecast of $22.00, and a low forecast of $21.00.
The average price target represents a +4.87% change from the last price of $20.34.
Highest Price Target
$22.00
Average Price Target
$21.33
Lowest Price Target
$21.00
SBRA Analyst Ratings
Hold
Based on 29 analysts giving stock ratings to Sabra Health Care REIT, Inc. in the past 3 months
EPS Estimates — SBRA
92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.54
vs Est $0.51
▲ 6.5% off
2025
Actual $0.64
vs Est $0.70
▼ 8.8% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.
Revenue Estimates — SBRA
97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.703B
vs Est $0.687B
▲ 2.3% off
2025
Actual $0.775B
vs Est $0.744B
▲ 3.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
